Emerging concepts in bioenergetics and cancer research: Metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy

International Journal of Biochemistry and Cell Biology

Volumn 59, Issue , 2015, Pages 167-181

  Obre, Emilie ^a   Rossignol, Rodrigue ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cancer; Metabolic flexibility; Mitochondria; Oncobioenergetics; Oxidative phosphorylation

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 6 DIAZO 5 OXONORLEUCINE; BZ 423; DEOXYGLUCOSE; ETOMOXIR; EVEROLIMUS; FATTY ACID; GLUTAMINASE; ISOSORBIDE; LONIDAMINE; METFORMIN; MYC PROTEIN; OLIGOMYCIN; PHENYLACETIC ACID; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE INHIBITOR; RAPAMYCIN; RIDAFOROLIMUS; TEMSIROLIMUS; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BIOENERGY; CANCER CELL; CANCER RESEARCH; CARCINOGENESIS; CELL SURVIVAL; CLINICAL TRIAL (TOPIC); ENERGY METABOLISM; ENVIRONMENTAL FACTOR; FATTY ACID OXIDATION; HEREDITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; METABOLIC DISORDER; METABOLIC REGULATION; METABOLISM; METABOLOMICS; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; SYMBIOSIS; ANIMAL; BIOLOGICAL MODEL; MEDICAL RESEARCH; NEOPLASMS; OXIDATION REDUCTION REACTION;

MUS;

ANIMALS; BIOMEDICAL RESEARCH; ENERGY METABOLISM; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; SYMBIOSIS;

EID: 84920814046     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.12.008     Document Type: Review

References (108)

1. Amoedo ND, Rodrigues MF, Rumjanek FD. Mitochondria: are mitochondria accessory to metastasis? Int J Biochem Cell Biol 2014;51(June):53-7, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24661997 [cited 27.07.14].
2. Baracca A, Chiaradonna F, Sgarbi G, Solaini G, Alberghina L, Lenaz G. Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. Biochim Biophys Acta 2010;1797(2):314-23, Available from: http://www.ncbi.nlm.nih.gov/pubmed/19931505
3. Benard G, Bellance N, Jose C, Melser S, Nouette-Gaulain K, Rossignol R. Multi-site control and regulation of mitochondrial energy production. Biochim Biophys Acta 2010;1797(6-7):698-709, Available from: http://www.ncbi.nlm.nih.gov/pubmed/20226160
4. Benard G, Trian T, Bellance N, Berger P, Lavie J, Espil-Taris C, et al. Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction. Antioxid Redox Signal 2012, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22369111
5. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006;126(1):107-20, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=16839880
6. Birk AV, Liu S, Soong Y, Mills W, Singh P, Warren JD, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 2013;24(July (8)):1250-61, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3736700&tool=pmcentrez&rendertype=Abstract [cited 03.12.14].
7. Bobrovskyy M, Vanderpool CK. Regulation of bacterial metabolism by small RNAs using diverse mechanisms. Annu Rev Genet 2013;47(January):209-32, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24016191 [cited 29.08.14].
8. Bulteau A-L, Ikeda-Saito M, Szweda LI. Redox-dependent modulation of aconitase activity in intact mitochondria. Biochemistry 2003;42(December (50)):14846-55, Available from: http://www.ncbi.nlm.nih.gov/pubmed/14674759 [cited 13.05.14].
9. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB, et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 2012;22(4):547-60, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23079663
10. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. III. The steady state. J Biol Chem 1955;217(1):409-27, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=13271404
11. Chance B, Williams GR. The respiratory chain and oxidative phophorylation. Adv Enzymol Relat Subj Biochem 1956;17:65-134.
12. Chapiro J, Sur S, Savic LJ, Ganapathy-Kaniappan S, Reyes J, Duran R, et al. Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. Clin Cancer Res 2014(October).
13. Cheng T, Sudderth J, Yang C, Mullen AR, Jin ES, Matés JM, et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci U S A 2011;108(May (21)):8674-9, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3102381&tool=pmcentrez&rendertype=Abstract [cited 22.03.14].
14. Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 2013;155(September (1)):160-71, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3790458&tool=pmcentrez&rendertype=Abstract [cited 29.04.14].
15. Corazao-Rozas P, Guerreschi P, Jendoubi M, André F, Jonneaux A, Scalbert C, et al. Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor. Oncotarget 2013;4(November (11)):1986-98, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3875764&tool=pmcentrez&rendertype=Abstract [cited 10.10.14].
16. Curtis JM, Hahn WS, Long EK, Burrill JS, Arriaga EA, Bernlohr DA. Protein carbonylation and metabolic control systems. Trends Endocrinol Metab 2012;23(August (8)):399-406, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3408802&tool=pmcentrez&rendertype=Abstract [cited 13.05.14].
17. da-Silva WS, Gómez-Puyou A, de Gómez-Puyou MT, Moreno-Sanchez R, De Felice FG, de Meis L, et al. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J Biol Chem 2004;279(September (38)):39846-55, Available from: http://www.ncbi.nlm.nih.gov/pubmed/15247300 [cited 07.08.14].
18. Davis MI, Gross S, Shen M, Straley KS, Pragani R, Lea Wa, et al. Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1. J Biol Chem 2014;289(May (20)):13717-25.
19. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 2007;104(49):19345-50, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=18032601
20. Emadi A, Jun SA, Tsukamoto T, Fathi AT, Minden MD, Dang CV. Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations. Exp Hematol 2014;42(April (4)):247-51, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24333121 [cited 26.08.14].
21. Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab 2013;17(January (1)):113-24, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3545102&tool=pmcentrez&rendertype=Abstract [cited 05.05.14].
22. Favier J, Amar L, Gimenez-Roqueplo A-P. Paraganglioma and pheochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 2014;November, Available from: http://www.ncbi.nlm.nih.gov/pubmed/25385035 [cited 01.12.14].
23. Fendt SM, Bell EL, Keibler MA, Olenchock BA, Mayers JR, Wasylenko TM, et al. Reductive glutamine metabolism is a function of the alpha-ketoglutarate to citrate ratio in cells. Nat Commun 2013;4:2236, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23900562
24. Finley LWS, Haas W, Desquiret-Dumas V, Wallace DC, Procaccio V, Gygi SP, et al. Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE 2011;6(January (8)):e23295, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3157345&tool=pmcentrez&rendertype=Abstract [cited 11.12.14].
25. Frezza C. The role of mitochondria in the oncogenic signal transduction. Int J Biochem Cell Biol 2014;48(March):11-7, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24397955 [cited 20.07.14].
26. Frijhoff J, Dagnell M, Augsten M, Beltrami E, Giorgio M, Östman A. The mitochondrial reactive oxygen species regulator p66Shc controls PDGF-induced signaling and migration through protein tyrosine phosphatase oxidation. Free Radic Biol Med 2014;68(March):268-77, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24378437 [cited 11.12.14].
27. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007;129(1):111-22, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=17418790
28. Galina A. Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity. Int J Biochem Cell Biol 2014(May), Available from: http://www.ncbi.nlm.nih.gov/pubmed/24842108 [cited 07.08.14].
29. Gasparre G, Kurelac I, Capristo M, Iommarini L, Ghelli A, Ceccarelli C, et al. A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function. Cancer Res 2011;71(19):6220-9, Available from: http://www.ncbi.nlm.nih.gov/pubmed/21852384
30. Gellerich FN, Gizatullina Z, Gainutdinov T, Muth K, Seppet E, Orynbayeva Z, et al. The control of brain mitochondrial energization by cytosolic calcium: the mitochondrial gas pedal. IUBMB Life 2013;65(March (3)):180-90, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23401251 [cited 13.05.14].
31. Glick GD, Rossignol R, Lyssiotis CA, Wahl D, Lesch C, Sanchez B, et al. Targeting increased anaplerotic metabolism of pathogenic T cells to treat immune disease. J Pharmacol Exp Ther 2014(August), Available from: http://www.ncbi.nlm.nih.gov/pubmed/25125579 [cited 26.08.14].
32. Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol 2009;41(10):1837-45, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=19467914
33. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009;324(5935):1713-6, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=19556508
34. De Groof AJ, te Lindert MM, van Dommelen MM, Wu M, Willemse M, Smift AL, et al. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer 2009;8:54, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=19646236
35. Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 2003;546(1):113-20, Available from: http://www.ncbi.nlm.nih.gov/pubmed/12829246
36. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005;8(4):311-21, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=16226706
37. Herzig S, Raemy E, Montessuit S, Veuthey J-L, Zamboni N, Westermann B, et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science 2012;337(July (6090)):93-6, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22628554 [cited 13.05.14].
38. Hitosugi T, Zhou L, Elf S, Fan J, Kang H-B, Seo JH, et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 2012;22(November (5)):585-600, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3500524&tool=pmcentrez&rendertype=Abstract [cited 07.08.14].
39. Hu S, Balakrishnan A, Bok RA, Anderton B, Larson PEZ, Nelson SJ, et al. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metab 2011;14(July (1)):131-42, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3858338&tool=pmcentrez&rendertype=Abstract [cited 07.08.14].
40. James AM, Collins Y, Logan A, Murphy MP. Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 2012;23(September (9)):429-34, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22831852 [cited 20.03.14].
41. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013;493(January (7434)):689-93, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3561500&tool=pmcentrez&rendertype=Abstract [cited 22.07.14].
42. Johnson SC, Yanos ME, Kayser E-B, Quintana A, Sangesland M, Castanza A, et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 2013;342(December (6165)):1524-8, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4055856&tool=pmcentrez&rendertype=Abstract [cited 11.12.14].
43. Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 2011a;1807(6):552-61, Available from: http://www.ncbi.nlm.nih.gov/pubmed/20955683
44. Jose C, Hebert-Chatelain E, Bellance N, Larendra A, Su M, Nouette-Gaulain K, et al. AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation. Biochim Biophys Acta 2011b;1807(6):707-18, Available from: http://www.ncbi.nlm.nih.gov/pubmed/21692240
45. Jose C, Melser S, Benard G, Rossignol R. Mitoplasticity: adaptation biology of the mitochondrion to the cellular redox state in physiology and carcinogenesis. Antioxid Redox Signal 2013;18(7):808-49, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22989324
46. Jose C, Rossignol R. Rationale for mitochondria-targeting strategies in cancer bioenergetic therapies. Int J Biochem Cell Biol 2013;45(1):123-9, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22776740
47. Kennedy KM, Scarbrough PM, Ribeiro A, Richardson R, Yuan H, Sonveaux P, et al. Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLOS ONE 2013;8(January (9)):e75154, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3771963&tool=pmcentrez&rendertype=Abstract [cited 09.10.14].
48. Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, et al. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res 2012;72(October (19)):5035-47, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22865452 [cited 10.10.14].
49. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 2010;107(February (5)):2037-42.
50. Lopes Costa A, Le Bachelier C, Mathieu L, Rotig A, Boneh A, De Lonlay P, et al. Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling. Hum Mol Genet 2014;23(April (8)):2106-19, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24365713 [cited 13.05.14].
51. Lu C, Thompson CB. Metabolic regulation of epigenetics. Cell Metab 2012;16(July (1)):9-17, Available from: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=3392647&tool=pmcentrez&rendertype=Abstract [cited 11.07.14].
52. Lustig Y, Ruas JL, Estall JL, Lo JC, Devarakonda S, Laznik D, et al. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase. Genes Dev 2011;25(June (12)):1232-44, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3127426&tool=pmcentrez&rendertype=Abstract [cited 13.05.14].
53. Maddocks OD, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 2013;493(7433):542-6, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23242140
54. Mailloux RJ, Xuan JY, McBride S, Maharsy W, Thorn S, Holterman CE, et al. Glutaredoxin-2 is required to control oxidative phosphorylation in cardiac muscle by mediating deglutathionylation reactions. J Biol Chem 2014;289(May (21)):14812-28, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24727547 [cited 11.12.14].
55. Marin-Valencia I, Cho SK, Rakheja D, Hatanpaa KJ, Kapur P, Mashimo T, et al. Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors. NMR Biomed 2012a;25(10):1177-86, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22383401
56. Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang XL, et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 2012b;15(6):827-37, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22682223
57. Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Ketone body utilization drives tumor growth and metastasis. Cell Cycle 2012;11(November (21)):3964-71, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3507492&tool=pmcentrez&rendertype=Abstract [cited 13.05.14].
58. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, et al. p53 regulates mitochondrial respiration. Science 2006;312(5780):1650-3, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=16728594
59. Melser S, Chatelain EH, Lavie J, Mahfouf W, Jose C, Obre E, et al. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab 2013;17(5):719-30, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23602449
60. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012;481(7381):380-4, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22101433
61. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 1961;191:144-8.
62. Mochly-Rosen D, Disatnik M-H, Qi X. The challenge in translating basic research discoveries to treatment of Huntington disease. Rare Dis (Austin, TX) 2014;2(January):e28637, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4091548&tool=pmcentrez&rendertype=Abstract [cited 11.08.14].
63. Morton R, Cunningham C, Jester R, Waite M, Miller N, Morris HP. Alteration of mitochondrial function and lipid composition in Morris 7777 hepatoma. Cancer Res 1976;36(9 pt.1):3246-54, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=184946
64. Mouchiroud L, Eichner LJ, Shaw RJ, Auwerx J, Transcriptional coregulators: fine-tuning metabolism. Cell Metab 2014;20(July (1)):26-40, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24794975 [cited 23.07.14].
65. Mullen AR, Wheaton WW, Jin ES, Chen P-HH, Sullivan LB, Cheng T, et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012a;481(January (7381)):385-8, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3262117&tool=pmcentrez&rendertype=Abstract [cited 20.03.14].
66. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012b;481(7381):385-8, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22101431
67. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26(3):268-70, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=11062460
68. Ostojić J, Panozzo C, Lasserre J-P, Nouet C, Courtin F, Blancard C, et al. The energetic state of mitochondria modulates complex III biogenesis through the ATP-dependent activity of Bcs1. Cell Metab 2013;18(October (4)):567-77, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24055101 [cited 13.05.14].
69. Palmieri F, Pierri CL. Mitochondrial metabolite transport. Essays Biochem 2010;47(January):37-52, Available from: http://www.ncbi.nlm.nih.gov/pubmed/20533899 [cited 24.04.14].
70. Palorini R, Cammarata F, Balestrieri C, Monestiroli A, Vasso M, Gelfi C, et al. Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response. Cell Death Dis 2013;4:e732, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23868065
71. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321(5897):1807-12, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=18772396
72. Patra KC, Wang Q, Bhaskar PT, Miller L, Wang Z, Wheaton W, et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell 2013;24(August (2)):213-28, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23911236 [cited 07.08.14].
73. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009;8(23):3984-4001, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=19923890
74. Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta 2002;1555(1-3):14-20, Available from: http://www.ncbi.nlm.nih.gov/htbinpost/Entrez/query?db=m&form=6&dopt=r&uid=12206885
75. Peinado JR, Diaz-Ruiz A, Frühbeck G, Malagon MM. Mitochondria in metabolic disease: getting clues from proteomic studies. Proteomics 2014;14(March (4-5)):452-66, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24339000 [cited 13.05.14].
76. Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 2005;14(15):2231-9, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=15987702
77. Porporato PE, Payen VL, Pérez-Escuredo J, De Saedeleer CJ, Danhier P, Copetti T, et al. A mitochondrial switch promotes tumor metastasis. Cell Rep 2014(July), Available from: http://www.ncbi.nlm.nih.gov/pubmed/25066121 [cited 24.07.14].
78. Reitzer LJ, Wice BM, Kennel D. Evidence that glutamine, not sugar, is the major energy source for cultured Hela cells. J Biol Chem 1979;254(April):2669-76.
79. Rezvani HR, Kim AL, Rossignol R, Ali N, Daly M, Mahfouf W, et al. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest 2011;121(1):195-211, Available from: http://www.ncbi.nlm.nih.gov/pubmed/21123941
80. Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell 2013;23(June (6)):811-25, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23764003 [cited 28.03.14].
81. Rossignol R, Letellier T, Malgat M, Rocher C, Mazat JP. Tissular variation in the control of oxidative phosphorylations, implication for mitochondrial diseases. Biochem J 2000;347:45-53.
82. Saada A. Mitochondria: mitochondrial OXPHOS (dys) function ex vivo-the use of primary fibroblasts. Int J Biochem Cell Biol 2014;48(March):60-5, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24412346 [cited 13.05.14].
83. Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest 2010;120(January (1)):142-56, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2799198&tool=pmcentrez&rendertype=Abstract [cited 13.05.14].
84. Schagger H. Blue-native gels to isolate protein complexes from mitochondria. Methods Cell Biol 2001;65:231-44, Available from: http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=11381596
85. Schägger H, Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J 2000;19(8):1777-83.
86. Scheffler IE. Mitochondria. New York: John Wiley & Sons; 1999. p. 364 pp.
87. Scotland S, Saland E, Skuli N, de Toni F, Boutzen H, Micklow E, et al. Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells. Leukemia 2013, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23568147
88. Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res 2010;70(November (22)):8981-7, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3058858&tool=pmcentrez&rendertype=Abstract [cited 21.08.14].
89. Shukla K, Ferraris DV, Thomas AG, Stathis M, Duvall B, Delahanty G, et al. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. J Med Chem 2012;55(December (23)):10551-63, http://dx.doi.org/10.1021/jm301191p.
90. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 2013;496(April (7443)):101-5, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3656466&tool=pmcentrez&rendertype=Abstract [cited 19.03.14].
91. Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008;118(December (12)):3930-42.
92. Stumpf CR, Moreno MV, Olshen AB, Taylor BS, Ruggero D. The translational landscape of the mammalian cell cycle. Mol Cell 2013;52(November (4)):574-82, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24120665 [cited 29.08.14].
93. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 2014;171(April (8)):2029-50, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24117165 [cited 12.08.14].
94. Telang S, Lane AN, Nelson KK, Arumugam S, Chesney J. The oncoprotein H-RasV12 increases mitochondrial metabolism. Mol Cancer 2007;6:77, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=18053146
95. Vozza A, Parisi G, De Leonardis F, Lasorsa FM, Castegna A, Amorese D, et al. UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci U S A 2014;111(January (3)):960-5, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3903233&tool=pmcentrez&rendertype=Abstract [cited 22.07.14].
96. Warburg O. Metabolism of tumors. London: Arnold Constable; 1930.
97. Wei B-R, Simpson RM, Johann DJ, Dwyer JE, Prieto DA, Kumar M, et al. Proteomic profiling of H-Ras-G12V induced hypertrophic cardiomyopathy in transgenic mice using comparative LC-MS analysis of thin fresh-frozen tissue sections. J Proteome Res 2012;11(March (3)):1561-70, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22214408 [cited 28.03.14].
98. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 2010;107(19):8788-93, Available from: http://www.ncbi.nlm.nih.gov/pubmed/20421486
99. Weinhouse S. On respiratory impairment in cancer cells. Science 1956;124:267-8.
100. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009;324(5930):1076-80, Available from: http://www.ncbi.nlm.nih.gov/pubmed/19461003
101. White UA, Stephens JM. Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol 2010;318(April (1-2)):10-4, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3079373&tool=pmcentrez&rendertype=Abstract [cited 18.08.14].
102. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A 2008;105(48):18782-7, Available from: http://www.ncbi.nlm.nih.gov/pubmed/19033189
103. Wolf DA. Is reliance on mitochondrial respiration a "chink in the armor" of therapyresistant cancer? Cancer Cell 2014;26(December (6)):788-95, Available from: http://www.ncbi.nlm.nih.gov/pubmed/25490445 [cited 10.12.14].
104. Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A 2012;109(May (18)):6904-9, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3345000&tool=pmcentrez&rendertype=Abstract [cited 28.03.14].
105. Yizhak K, Le Dévédec SE, Rogkoti VM, Baenke F, de Boer VC, Frezza C, et al. A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol Syst Biol 2014;10(January (8)):744, Available from: http://www.ncbi.nlm.nih.gov/pubmed/25086087 [cited 05.08.14].
106. Zhang Z, Falk MJ. Integrated transcriptome analysis across mitochondrial disease etiologies and tissues improves understanding of common cellular adaptations to respiratory chain dysfunction. Int J Biochem Cell Biol 2014;50(May):106-11, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24569120 [cited 13.05.14].
107. Zhang Z, Tsukikawa M, Peng M, Polyak E, Nakamaru-Ogiso E, Ostrovsky J, et al. Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network. PLOS ONE 2013;8(7):e69282, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23894440
108. Zirath H, Frenzel A, Oliynyk G, Segerström L, Westermark UK, Larsson K, et al. MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells. Proc Natl Acad Sci U S A 2013;110(June (25)):10258-63, Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3690852&tool=pmcentrez&rendertype=Abstract [cited 27.03.14].